COVID-19 rapid guideline: delivery of systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
PHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
NICE guideline on the treatment of human and animal bites
This summary provides an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.
SIGN guideline on bacterial UTIs in women
This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
COVID-19 rapid guideline: managing COVID-19 symptoms in the community
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
Resource hub
WHO COVID-19 clinical management guideline
COVID-19 rapid guideline: delivery of systemic anticancer treatments
PHE management of patient/staff exposure to COVID-19
PHE influenza immunisation policy
PHE MenACWY vaccine guideline
WHO updates COVID-19 treatment guideline
General practice in the context of coronavirus (COVID-19)
NHS England COVID-19 vaccination SOP
PHE Zika virus guidance for pregnant women
NHIVNA annual health review
- Previous
- Next